D
ue to the increasing prevalence of obesity in Western countries, the use of thermogenic dietary supplements is becoming more frequent. Toxic leukoencephalopathy may be caused by exposure to a wide variety of agents, including cranial irradiation, therapeutic agents, illicit drugs, and environmental toxins (1) . Its association with a thermogenic supplement has not been reported. Such is the purpose of this report.
CASES
Pertinent fi ndings for the two patients are summarized in Table 1 . Magnetic resonance imaging (MRI) during the acute episode in both patients revealed extensive symmetric restricted diff usion involving the entire corpus callosum, the pons, and subcortical white matter with reduced apparent diff usion coeffi cient values. No abnormal enhancement was seen (Figures 1  to 3 ).
Both women were using the dietary thermogenic supplement Th ermatrim for weight loss. Th e fi rst patient had taken the supplement within the previous 2 months, and the second patient within the previous 3 weeks. Th ey received supportive therapy and recovered within 2 to 5 days. Both patients had a benign clinical course with progressive clinical improvement and were discharged within the fi rst week of admission. Two-month follow-up MRI of the fi rst patient showed almost complete resolution of the fi ndings.
DISCUSSION
Leukoencephalopathy describes the structural changes of cerebral white matter in which myelin suff ers the most extensive damage (1) . Th e neurological fi ndings in acute toxic leukoencephalopathy can reverse with prompt recognition and with-drawal of the off ending agent (2) . Defi nite fi ndings on MRI to predict reversible versus irreversible and severe outcomes have not been determined.
Similar though less extensive fi ndings have been described in the clinicoradiological syndrome of mild encephalitis/encephalopathy with reversible splenial and white matter lesions (MERS Type II). Th is entity presents in patients with clinically mild encephalopathy and reversible lesions involving the entire corpus callosum with bilateral extension into the subcortical white matter (3, 4) . First reports described this rare entity in patients who had seizures with secondary generalization (5) and in patients with toxicity or drug sensitivity to antiepileptic drugs (6) . Subsequently, this entity has widened its spectrum and has been associated with diff erent clinical neurologic and nonneurologic conditions, including postinfectious disorder (7), rapid withdrawal of antiepileptic drugs (8), high-altitude cerebral edema (9) , and various metabolic disorders (hypoglycemia and hypernatremia) (10) . Due to the heterogeneous entities linked to mild encephalitis/encephalopathy with reversible splenial and white matter (12), alteration of the arginine-vasopressin system which may aff ect brain hydric content (13) , and development of an infl ammatory infi ltrate with infl ux of infl ammatory cells and molecules possibly combined with related cytotoxic edema (14) . Th e usage of thermogenic dietary supplements is widespread for augmentation in overall metabolism and "fat burning" in expectation to support weight loss by the consumer. Th ermatrim is a thermogenic dietary supplement marketed via the Internet and available to the general public. Its contents profi le states it contains garcinia cambogia, chromium picolinate, chitosan, equisetum arvense, momordica charantia, herbal sources of caffeine such as guarana, and other purported metabolic-supporting ingredients such as carnitine and Ilex paraguariensis, though there is a lack of information on the quantities of ingredients and other specifi c product information.
Th ermogenic supplements have been associated with signifi cant side eff ects, including anxiety, insomnia, cardiovascular disorders, and central nervous system stimulation, among others (15) . However, these reports originate from isolated case reports due to the lack of forthcoming users experiencing said adverse eff ects.
Th is is the fi rst time that reversible white matter lesions have been reported to be associated with a thermogenic dietary supplement. A larger series of patients needs to be studied to assess the specifi city and correlation of these fi ndings as a direct cause of acute leukoencephalopathy. Further product-specifi c research on thermogenic aids is needed to determine levels of eff ectiveness and safety for consumers. 
